Sustained virological response to hepatitis C treatment reduces mortality, liver cancer and liver transplants

Published: November 10, 2014

aidsmap
Liz Highleyman
Original Article:  bit.ly/1EwhcjO

People who achieve sustained virological response (SVR) when treated with interferon-based therapy for hepatitis C have a lower risk of death, are less likely to develop liver cancer and need fewer liver transplants than those who were treated but not cured, according to results from a meta-analysis of more than 34,000 patients presented Sunday at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting in Boston.

Hill noted that many of the coinfected patients were men who have sex with men. Starting around the year 2000, outbreaks of apparently sexually transmitted HCV infection have been widely reported among HIV-positive gay and bisexual men in cities in Europe, the US and Australia. He said this analysis could not provide details about specific risk factors, but the highest re-infection rate was seen among coinfected people who also injected drugs.

Full text of article available at link below:  bit.ly/1EwhcjO

Leave a Reply